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2ABSTRACT
We describe for the first time the enzymatic acylation of the phenolic group of tocopherols 
(vitamin E) by transesterification with vinyl acetate in 2-methyl-2-butanol (2M2B). Out of 15 
hydrolases screened, only the lipase B from Candida antarctica (Novozym 435) catalyzed 
the acylation. The acetylation of -tocopherol was faster than that of -tocopherol, probably
due to its lower methylation degree. A series of experiments using (R)-Trolox and p-cresol as 
competitive acceptors of tocopherols showed that reaction rate notably diminished when 
increasing acceptor size. To maximize the potential of this reaction, three immobilization 
carriers for C. antarctica lipase B were studied: the ion-exchange resin Lewatit (the support 
in Novozym 435), a biodegradable polymer (Purasorb) and polypropylene (Accurel EP100). 
The acetylation of -tocopherol was faster with the enzyme immobilized in polypropylene, 
which was correlated with its higher porosity. A mixture hexane/2M2B 90:10 (v/v) was found 
to be the optimum medium composition, as it represents a compromise between substrates 
solubility and biocatalyst efficiency. The acylation process was no enantioselective, probably 
due to the fact that the chiral centers are separated from the phenolic group by a minimum of 
six bonds. 
Key words: immobilization, lipases, transesterification, Novozym 435, tocopherols, 
antioxidants modification.
31. INTRODUCTION
Antioxidants protect cells against the effects of harmful free radicals and play an 
important role in preventing many human diseases (e.g. cancer, atherosclerosis, stroke, 
rheumatoid arthritis, neurodegeneration, inflammatory disorders, diabetes) and aging itself
[1;2]. The study of antioxidants is of great interest for the role they play in protecting living 
systems against lipid peroxidation and other anomalous molecular modifications [3]. In 
addition, antioxidant molecules also prevent unsaturated oil products from becoming rancid 
during storage, thus extending its shelf life [4;5].
Among the natural antioxidants, the term vitamin E describes the beneficial biological 
activity on humans and animals of a group of structurally related compounds, in particular , 
-,  and -tocopherol, plus, -,  and -tocotrienol [6]. Vitamin E enhances the 
oxidative stability of the organisms owing to its ability to protect polyunsaturated fatty acids 
from peroxidation and to scavenge free radicals. Tocopherols have three chiral centers at 
carbons 2, 4’- and 8’-, and the naturally occurring isomer has the RRR-configuration (Fig. 1), 
whereas tocotrienols have only one anomeric center at carbon 2 [7]. It is generally accepted
that the RRR--tocopherol is the most bioactive compound [8] as it is specifically recognized 
by membranes [9]. For example, the isomer with inverted stereochemistry at position 2 has 
only 30% of the biological activity of the RRR isomer. The synthetic vitamin E (-tocopherol) 
is obtained by reaction of trimethylhydroquinone with isophytol [10], without any control of 
stereochemistry, and comprises a mixture of four pairs of enantiomers in equal amounts (all-
rac). Synthetic tocopherols are not as biologically active as natural, due to non-active 
stereoisomers [11].
To increase its stability in the presence of light and oxygen and/or to alter its physical 
properties such as solubility and miscibility, vitamin E is generally administered as a prodrug
in the form of all-rac--tocopheryl acetate (vitamin E acetate) or all-rac--tocopheryl 
succinate (vitamin E succinate). These derivatives carry an acetyl moiety at the C-6 phenolic 
group that blocks the antioxidant properties [12]. However, unspecific esterases rapidly 
4cleave in vivo the ester bond and release the active -tocopherol. The vitamin E acetate is 
synthesized by chemical acylation of all-rac--tocopherol with acetic acid or acetic anhydride
as acyl donors and a metal catalyst [13]. The enzymatic acetylacion or succinylation of 
vitamin E has not been described before, probably due to the large molecular size of the 
acceptor (tocopherol) and its steric hindrance within the active site of the enzyme. 
In the present work, we have studied the enzymatic synthesis of vitamin E acetate by 
lipase-catalyzed transesterification and the effect of immobilization carrier and solvent
composition on acylation rate. Our results suggest that Candida antarctica lipase B offers 
appropriate tools for the transformation of vitamin E under mild conditions.
52. EXPERIMENTAL PROCEDURES
Materials
Immobilized lipase from C. antarctica B (Novozym 435) was kindly donated by Novozymes 
A/S. A small sample of lipase B from C. antarctica adsorbed on Accurel EP100 and Purasorb 
was prepared by Novozymes A/S in the context of the collaborative EU project BIO4-CT98-
0363 following the protocol previously reported [14]. All-rac--tocopherol was kindly provided 
by Biotecnologías Aplicadas (BTSA, Madrid, Spain). Tributyrin, RRR--tocopherol, methyl 
laurate, propyl laurate and 2-methyl-2-butanol (tert-amyl alcohol) were from Sigma. (R)-6-
hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid [(R)-Trolox], vinyl acetate and p-
cresol were from Aldrich. Solvents were dried over 3 Å molecular sieves. All other reagents 
were of the highest available purity and used as purchased.
Hydrolytic activity
The hydrolytic activity was measured titrimetrically at pH 7.0 and 30 C using a pH-stat 
(Mettler, Model DL 50). The reaction mixture consisted of 0.8 ml tributyrin (64.2 mM final 
concentration in the vessel), 1.2 ml acetonitrile and 40 ml of 1 mM Tris-HCl buffer (pH 7.0) 
containing 0.1 M NaCl. The immobilized biocatalyst (5 mg) was then added and the pH 
automatically maintained at 7.0 using 0.1 N NaOH as titrant. Experiments were done in 
triplicate. One enzyme unit (U) was defined as that catalyzing the formation of 1 µmol of fatty 
acid per min.
Synthetic activity
To determine the activity in synthesis, methyl laurate (50 mM) and 1-propanol (50 mM) were 
dissolved in 5 ml hexane in a screw-capped test vial, and stirred for 15 min at 30 °C. Then, 
the immobilized biocatalyst (75 mg) was added, and the mixture incubated at 30 °C and 150 
rpm using an orbital shaker (Stuart Scientific). At defined intervals, 50 µl aliquots were taken, 
6centrifuged and filtered using an eppendorf tube with a 0.45 m filter (Ultrafree-MC, 
Millipore). The formation of propyl laurate was followed by HPLC. One enzyme unit (U) was 
defined as that catalyzing the formation of 1 µmol of propyl laurate per min.
Water activity 
Water activity was determined using a humidity and temperature digital indicator Novasina 
Thermoconstanter TH200 (Novasina, Switzerland). The humidity sensor was calibrated with 
control saturated salts solutions (LiCl, aw=0.11; potassium acetate, aw=0.22; NaBr, aw=0.57; 
NaCl, aw=0.75) at 25 ºC. 
Enzymatic acetylation of tocopherols
Tocopheryl acetate was synthesized by transesterification of vinyl acetate (100-400 mM) with 
-tocopherol or -tocopherol (25-100 mM). Reactions were carried out in 2-methyl-2-butanol 
(2M2B) in sealed 30 ml dark vials at 60 ºC with orbital stirring (190 rpm). Reaction volume 
was 5 ml. The biocatalyst was added to a final concentration of 100 mg/ml. Aliquots (200 l) 
were removed at intervals, filtered using an eppendorf tube containing a Durapore® 0.45 m 
filter and analyzed by HPLC. 
Competitive acetylation experiments
-Tocopherol or -tocopherol (50 mM) and (R)-Trolox or p-cresol (50 mM) were dissolved in 
2M2B containing vinyl acetate (400 mM). Reactions were carried out at 60 ºC with orbital 
shaking (190 rpm) in sealed 30 ml vials. Reaction volume was 5 ml. The biocatalyst was
added to a final concentration of 100 mg/ml. Aliquots (200 l) were removed at intervals, 
filtered using an eppendorf tube with a 0.45 m filter (Ultrafree-MC, Millipore), and analyzed 
by HPLC. 
7HPLC analysis
For HPLC analysis, a ternary pump (model 9012, Varian) coupled to a thermostatized (15 ºC) 
autosampler (VWR Hitachi L-2200) was used. The temperature of the column was kept 
constant at 45 C (oven model MEF-01, Análisis Vínicos, Spain). Detection was performed 
using a photodiode array detector (ProStar, Varian), and integration was carried out using 
the Varian Star LC workstation 6.41. For tocopheryl acetate synthesis, the column was a 
Lichrospher 100 RP8 (4.6 x 125 mm, 5 m, Análisis Vínicos). Mobile phase was 95:5 (v/v) 
methanol:water (water contained 0.1% of acetic acid) at 1 ml/min. The reaction products
were quantified by measuring the absorbance at 240 nm. For propyl laurate synthesis, the 
column was a Mediterranea-C18 (4.6 x 150 mm, 5 m, Teknokroma, Spain). The mobile 
phase was 95:5 (v/v) methanol:water (water contained 0.1% of acetic acid) at 1.2 ml/min, 
and the analytes were quantified by measuring the absorbance at 216 nm.
HPLC/MS
To confirm the nature of the acetylated phenolic derivatives, samples were analyzed by 
HPLC coupled to mass spectrometry (using a HPLC1100 equipment, Agilent Technologies). 
Chromatographic conditions were as described above, except for the mobile phase 
contained 1% (v/v) formic acid and the flow rate was lowered to 0.6 ml/min. Ionization was 
performed by electrospray and the mass spectrometer had a hybrid analyzer QTOF model
(QSTAR pulsar, Applied Biosystems). 
Characterization of immobilized biocatalysts
Mercury intrusion porosimetry analyses of the biocatalysts were performed using a Fisons 
Instruments Pascal 140/240 porosimeter. To ensure that the samples were moisture free, 
they were dried at 100 ºC overnight, prior to measurement. Assuming a cylindrical pore 
model, the recommended values for the mercury contact angle (141°) and surface tension 
(484 mN/m) were used to evaluate the pressure/volume data by the Washburn equation. The 
8specific surface area (SBET) of the supports was determined from analysis of nitrogen 
adsorption isotherms at -196 °C. The samples were previously degassed at 100 °C for 12 h 
to a residual vacuum of 5x10-3 torr, to remove any loosely held adsorbed species, using a 
Micromeritics ASAP 2010 device. Water content of the supports was assayed using a DL31 
Karl-Fisher titrator (Mettler). Scanning electron microscopy (SEM) was performed using an 
XL3 microscope (Philips) on samples previously metallized with gold.
93. RESULTS AND DISCUSSION
3.1. Enzyme screening for acetylation of tocopherols.
Approximately 15 hydrolases (Table 1) were screened for the transesterification of vinyl 
acetate with all-rac--tocopherol in 2-methyl-2-butanol (2M2B). Four esterases from bovine 
rumen microflora [15] and one from Urania hypersaline basin [16], obtained using 
metagenomic techniques, were tested . An sterol esterase from the ascomycete Ophiostoma 
piceae obtained as previously described [17] was also assayed. Some of the hydrolases
were previously immobilized in Celite or in epoxy-activated Dilbeads TA [18].  Screening
conditions were: 50 mM -tocopherol, 150 mM vinyl acetate, 20 mg/ml biocatalyst, 40 ºC. 
Among all the enzymes tested, only the immobilized lipase B from C. antarctica (Novozym 
435) catalyzed this reaction significantly, although the acylation was slow compared with 
other processes involving the same biocatalyst and more simple primary or secondary 
alcohols. For the rest of hydrolases, -tocopherol was probably too large to fit into the 
acceptor binding site and thus attack the intermediate acetyl-enzyme yielding the tocopheryl 
ester [19]. The lipases from Candida rugosa and Pseudomonas cepacia, despite their
notable transesterification activity towards large hydroxylated substrates [20], did not 
catalyze the acetylation of vitamin E.  By computational conformation studies, it has been
demonstrated that the acceptor binding site of lipase B from C. antarctica is deep (compared 
with other lipases, e.g. from Thermomyces lanuginosus) [21], which partly explains the 
broader specificity of C. antarctica lipase B [22;23]. In addition, Salis et al. reported that the 
atypical lipase B from C. antarctica is very well adapted for catalysis in organic media [24]. In 
fact, the lipase B from C. antarctica is the preferred biocatalyst for many esterification and 
transesterification processes [25], including the modification of antioxidants [26-30].
To our knowledge, this is the first evidence on enzymatic acetylation of vitamin E. 
Tocopheryl acetate is normally obtained by a metal-catalyzed reaction using a great excess 
of acyl donor [31], but these routes do not meet the necessary requirements for food 
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applications. In contrast, this biocatalytic process is performed under milder conditions and 
thus is closer to the green chemistry [32]. 
3.2. Effect of acceptor molecular size.
A comparative study was carried out assaying - and -tocopherol as acceptors under 
more drastic conditions than in the initial screening. We first analyzed the effect of the molar 
ratio tocopherol:vinyl acetate (data not shown). We found that a molar ratio 1:4 was optimal
in terms of acylation rate without the need of increasing the concentration of acyl donor. Final 
conditions assayed were: 100 mM tocopherol, 400 mM vinyl acetate, 100 mg/ml biocatalyst, 
60 ºC. As shown in Fig. 2, the reaction rate was higher with -tocopherol, which rendered 
65% yield of acetylated product in approx. 2 weeks. The reproducibility of the assays was 
satisfactory, with standard deviations lower than 5 %. This different behaviour seems to be
related with the lower methylation degree of -tocopherol (Fig. 1), which diminishes the steric 
hindrance within the acceptor binding site.
The molecular weight of the synthesized products was determined by HPLC coupled to 
mass spectrometry to confirm their chemical nature (Fig. 3). In the case of -tocopherol 
reaction, the main peak at m/z 473.44 corresponded to the ([M+H]+) of -tocopherol acetate 
(MW 472.74). For -tocopherol acetate (MW 444.68), the main peak in the mass spectrum at 
m/z 462.44 corresponded to the ([M+NH4]
+) with a minor ([M+H]+) peak at 445.42.
It is well known that acyl-transfer reactions catalyzed by C. antarctica lipase B follow 
bi-bi ping-pong mechanism, and the alcohols used as acyl acceptors display competitive 
substrate inhibition [33]. A series of competitive reactions between tocopherol and other 
phenolic acceptors were performed to evaluate the effect of molecular size on the acylation 
rate. (R)-Trolox presents the same chromanol ring of -tocopherol −which is responsible of 
the antioxidant properties− but lacks of the aliphatic chain (Fig. 1), and p-cresol is quite a 
smaller molecule. Fig. 4 illustrates the reaction progress using the following pairs of 
acceptors: -tocopherol/(R)-Trolox, -tocopherol/(R)-Trolox, -tocopherol/p-cresol, -
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tocopherol/p-cresol. The formation of (R)-Trolox acetate and p-tolyl acetate was confirmed by 
HPLC/MS (data not shown). As depicted in Fig. 4, the reaction with Trolox was notably faster 
than the observed with - or -tocopherol, suggesting that the main steric hindrance is 
probably caused by the aliphatic chain rather than the chromanol ring. When using a simple 
phenol such as p-cresol, the reaction is nearly one order of magnitude faster than with 
tocopherols.
3.3. Effect of immobilization support.
Immobilization is a suitable approach to expose the enzyme more efficiently to the 
substrate, being specially indicated for synthetic processes in non-aqueous solvents [34]. 
Several parameters of immobilized lipases are important to consider for industrial application: 
mechanical strength, chemical and physical stability, hydrophobic/hydrophilic character, 
enzyme loading capacity and cost, to cite some. A comparative study with the C. antarctica
lipase B adsorbed on the ion-exchange resin Lewatit (Novozym 435), polypropylene (Accurel 
EP100) and Purasorb (a biodegradable polymer based on lactide and glycolide monomers)
was performed in the acetylation of -tocopherol (Fig. 5). The hydrolytic activity (measured 
with tributyrin) of the different immobilizates and their transesterification activity in a model 
reaction (methyl laurate with propanol in hexane to yield propyl laurate) are reported in Table 
2. It is interesting to note that Novozym 435 presents the highest hydrolytic and synthetic 
activities.
For -tocopherol acetylation, the biocatalysts were first dehydrated to reduce the total 
amount of water in the system and thus minimize the formation of acetic acid. Final water 
content was less than 1% w/w (Table 2). The hydrolysis of vinyl acetate to acetic acid is an 
undesirable side reaction also catalysed by the lipase, and competes with the acylation 
process. Most of the water in the reaction mixture comes from the biocatalyst and the 
solvents. A careful control of the amount of water in the system by addition of molecular 
sieves, drying the biocatalyst, etc. is crucial in terms of yield and downstream processing 
12
(the fatty acid must be removed from the final product). It has been reported that dehydration 
of the biocatalyst in a vacuum dessicator usually increases the transferase to hydrolase ratio 
[35]. However, water activity (aw) is preferred to water concentration for describing the 
hydration level of a system [14;36]. We measured the aw of the three biocatalysts assayed, 
and we found that the values were in the range 0.15-0.25.
The polypropylene biocatalyst gave rise to faster -tocopherol acetylation than 
Novozym 435 and Purasorb (Fig. 5). To explain these differences, the textural properties of 
the biocatalysts were measured by a combination of nitrogen adsorption and mercury 
porosimetry analyses (Table 2). Fig. 6 represents the total pore volume curves for these 
carriers. The polypropylene biocatalyst presented a substantially higher total pore volume 
(approx. 13 cm3/g) than Purasorb (0.8 cm3/g) and Lewatit (0.6 cm3/g). The average pore size 
was also larger for Accurel EP100 and Purasorb (100-900 nm) compared with Novozym 435 
(< 100 nm). The SEM pictures showed the presence in polypropylene of a channel structure 
(with diameters of approx. 10 m), which facilitates the internal diffusion of substrates and 
products (Fig. 7). The specific surface area of the three biocatalysts was low (< 70 m2/g) as 
expected for macroporous carriers. These results may help to explain the differences in 
acetylation of tocopherols, as large pores facilitate the contact between the enzyme and the 
bulky acceptor. Compared with the model transesterification reaction involving a small 
acceptor (propanol) in which Novozym 435 gave the highest activity (Table 2), the Accurel 
EP100 biocatalyst was the most efficient for acetylation of vitamin E. However, other 
parameters such as the local effects derived from the chemical nature of the carrier (esp. the 
hydrophobicity) may also exert an influence on the acylation rate.
3.4. Effect of medium composition and temperature.
The mixtures of miscible solvents have been successfully applied to the enzymatic 
regioselective acylation of several hydroxylic compounds [37-39]. These mixtures represent 
a compromise between substrates solubility and enzyme efficiency [19]. In the present work, 
several mixtures 2M2B/hexane were assayed in order to favour the solubilization of -
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tocopherol (Fig. 8). Using Novozym 435 as biocatalyst, the yield was higher when increasing 
hexane concentration up to 90% (v/v). However, a minimum of 10% (v/v) 2M2B was 
necessary for efficient transesterification, which seems to be related with the solubilization of 
vinyl acetate.
The effect of temperature (in the range 40-60 ºC) on -tocopherol acetylation in 
2M2B/hexane 90:10 (v/v) was analyzed (Fig. 9). The fastest reaction was observed at 60 ºC, 
at which C. antarctica lipase B is known to be highly stable and can be used without 
significant loss of activity even after several months [40].
3.5. Enantioselectivity of the process.
Attempts are being made to develop an efficient and stereocontrolled synthesis of the 
natural form of -tocopherol [41]. Considering the well-known stereospecificity of lipases 
[20;42], and in particular of the lipase B from C. antarctica [40;43], one could expect different 
acetylation rates for the eight stereoisomers present in synthetic all-rac--tocopherol. We 
measured the acetylation rate of all-rac--tocopherol and RRR--tocopherol to analyze the 
enantioselectivity of the process. Experimental conditions were: 100 mM -tocopherol, 400 
mM vinyl acetate, hexane/2M2B 90:10 (v/v), 100 mg/ml Novozym 435, 60 °C. We found that 
the acylation rate was very similar with both substrates (data not shown). This implies that 
the degree of chiral recognition is low, probably due to the fact that the chiral centers are 
separated by at least six bonds from the phenolic group that is being acetylated by the lipase 
(Fig. 1). In this context, Zahalka et al. succeeded in the enantiospecific hydrolysis of -
tocopheryl acetate by a cholesterol esterase [44]. They added chiral bile salts to emulsify the 
substrate, which may exert influences upon the epimeric acetates induced within the mixed 
micelle itself, or alternatively, may arise from direct bile salt-enzyme interactions. The nature 
of the solvent and the length of the acyl donor may also modulate the enantiopurity of the 
final product [45].
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Table 1. Screened hydrolases for acetylation of -tocopherol
Enzyme Physical state Origin
Lipase B from Candida antarctica Immobilized (Novozym 435) Novozymes A/S
Lipase from Thermomyces lanuginosus Immobilized (Lipozyme TL IM) Novozymes A/S
Lipase from Rhizomucor miehei Immobilized (Lipozyme RM IM) Novozymes A/S
Lipase from Pseudomonas cepacia Immobilized (Lipase I PS-C) Amano
Lipase from Alcaligenes sp. Immobilized (Lipase PLG) Meito Sangyo 
Lipase from Alcaligenes sp. Immobilized (Lipase QLG) Meito Sangyo
Cholesterol esterase from Pseudomonas sp. Powder Sigma
Cholesterol esterase from Ophiostoma piceae Immobilized in Dilbeads TA Fermentation
Lipase from porcine pancreas Powder Sigma
Lipase from Candida rugosa Powder Sigma
Protease from Bacillus licheniformes Immobilized in Dilbeads TA Sigma
Esterases from bovine rumen microflora Immobilized in Dilbeads TA Metagenome
Esterases from bovine rumen microflora Immobilized in Celite Metagenome
Esterase from Urania hypersaline basin Lyophilized Metagenome
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Table 2. Properties of the C. antarctica lipase B (CALB) immobilizates.
Water content (%) c
Immobilizate SBET (m
2/g) a
Pore volume 
(cm3/g) b
Before           After
Hydrolytic activity
(U/g biocatalyst) d
Transesterification 
activity
(U/g biocatalyst) e
Novozyme 435 68.6 0.6 2.2 0.9 2950 31.3
CALB/Accurel
EP100
67.8 13 1.9 0.7 2310 29.4
CALB/Purasorb 9.2 0.8 0.9 0.3 300 21.8
a Measured by N2 adsorption. 
b By combination of N2 isotherms and Hg porosimetry. 
c Determined by Karl-Fisher titration before and after dehydration. 
d Measured with tributyrin.
e Measured in the test reaction between methyl laurate and 1-propanol.
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Figure legends
Fig. 1. Structure of - and -tocopherol (the location of the three chiral centers is marked 
with an asterisk), (R)-Trolox and p-cresol.
Fig. 2. Kinetics of -tocopherol (O) and -tocopherol (●) acetylation in 2M2B catalyzed by 
Novozym 435. Experimental conditions: 100 mM - or -tocopherol, 400 mM vinyl acetate, 
100 mg/ml Novozym 435, 60 C.
Fig. 3. Molecular weight determination of -tocopheryl acetate (A) and -tocopheryl acetate 
(B) using HPLC-MS. 
Fig. 4. Competitive acetylation reactions in 2M2B between tocopherols and (R)-Trolox or p-
cresol catalyzed by Novozym 435. Experimental conditions: 50 mM - or -tocopherol, 50 
mM (R)-Trolox or p-cresol, 400 mM vinyl acetate, 100 mg/ml Novozym 435, 60 C.
Fig. 5. Kinetics of -tocopheryl acetate synthesis in 2M2B catalyzed by C. antarctica lipase B 
immobilized in three different supports: (▲) Accurel EP100; (O) Lewatit (Novozym 435); (■) 
Purasorb. Experimental conditions: 100 mM -tocoferol, 400 mM vinyl acetate, 100 mg/ml 
biocatalyst, 60 C.
Fig. 6. Total pore volume of the biocatalysts determined by combination of N2 adsorption and 
mercury intrusion porosimetry data. (A) Novozym 435; (B) CALB/Purasorb; (C) 
CALB/Accurel EP100.
Fig. 7. Scanning electron micrographs of the biocatalysts studied (A) 60x; (B) 500x.
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Fig. 8. Effect of hexane percentage (v/v) in mixtures 2M2B/hexane on -tocopheryl acetate 
synthesis. Experimental conditions: 100 mM -tocopherol, 400 mM vinyl acetate, 100 mg/ml
Novozym 435, 60 C. Yields refer to 6 days reaction.
Fig. 9. Effect of temperature on -tocopheryl acetate synthesis in hexane/2M2B 90:10 (v/v). 
Experimental conditions: 100 mM -tocopherol, 400 mM vinyl acetate, 100 mg/ml Novozym 
435. (●) 40 C ; (O) 50 C; (■)  60 C
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